Literature DB >> 26012366

Unsaturated Analogues of the Neurotransmitter GABA: trans-4-Aminocrotonic, cis-4-Aminocrotonic and 4-Aminotetrolic Acids.

Graham A R Johnston1.   

Abstract

Analogues of the neurotransmitter GABA containing unsaturated bonds are restricted in the conformations they can attain. This review traces three such analogues from their synthesis to their use as neurochemicals. trans-4-Aminocrotonic acid was the first conformationally restricted analogue to be extensively studied. It acts like GABA across a range of macromolecules from receptors to transporters. It acts similarly to GABA on ionotropic receptors. cis-4-Aminocrotonic acid selectively activates bicuculline-insensitive GABAC receptors. 4-Aminotetrolic acid, containing a triple bond, activates bicuculline-sensitive GABAA receptors. These findings indicate that GABA activates GABAA receptors in extended conformations and GABAC receptors in folded conformations. These and related analogues are important for the molecular modelling of ionotropic GABA receptors and to the development of new agents acting selectively on these receptors.

Entities:  

Keywords:  4-Aminotetrolic acid; GABA; GABAA receptors; GABAC receptors; cis-4-Aminocrotonic acid; trans-4-Aminocrotonic acid

Mesh:

Substances:

Year:  2015        PMID: 26012366     DOI: 10.1007/s11064-015-1619-9

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  43 in total

Review 1.  GABA-Activated ligand gated ion channels: medicinal chemistry and molecular biology.

Authors:  M Chebib; G A Johnston
Journal:  J Med Chem       Date:  2000-04-20       Impact factor: 7.446

2.  Evidence that GABA rho subunits contribute to functional ionotropic GABA receptors in mouse cerebellar Purkinje cells.

Authors:  Victoria L Harvey; Ian C Duguid; Cornelius Krasel; Gary J Stephens
Journal:  J Physiol       Date:  2006-08-31       Impact factor: 5.182

3.  Trans-4-aminocrotonic acid (TACA), a potent agonist of GABA(A) and GABA(C) receptors, shows a proconvulsant action in the electroconvulsive threshold test in mice.

Authors:  Kinga K Borowicz; Marek Zadrozniak; Stanisław J Czuczwar
Journal:  Pharmacol Rep       Date:  2005 Jan-Feb       Impact factor: 3.024

4.  GABA-induced calcium signaling in cultured enteric neurons is reinforced by activation of cholinergic pathways.

Authors:  H J Reis; P Vanden Berghe; M A Romano-Silva; T K Smith
Journal:  Neuroscience       Date:  2006-01-30       Impact factor: 3.590

5.  Transamination of analogues of gamma-aminobutyric acid by extracts of rat brain mitochondria.

Authors:  P M Beart; G A Johnston
Journal:  Brain Res       Date:  1973-01-30       Impact factor: 3.252

6.  4-aminotetrolic acid: new conformational-restricted analogue of -aminobutyric acid.

Authors:  P M Beart; D R Curtis; G A Johnston
Journal:  Nat New Biol       Date:  1971-11-17

7.  Comparative stereostructure-activity studies on GABAA and GABAB receptor sites and GABA uptake using rat brain membrane preparations.

Authors:  E Falch; A Hedegaard; L Nielsen; B R Jensen; H Hjeds; P Krogsgaard-Larsen
Journal:  J Neurochem       Date:  1986-09       Impact factor: 5.372

8.  A comparison of gamma-aminobutyric acid and the semi-rigid analogues 4-aminotetrolic acid, 4-aminocrotonic acid and imidazole-4-acetic acid on the isolated superior cervical ganglion of the rat.

Authors:  N G Bowery; G P Jones
Journal:  Br J Pharmacol       Date:  1976-03       Impact factor: 8.739

9.  Functional evidence for GABA as modulator of the contractility of the longitudinal muscle in mouse duodenum: role of GABA(A) and GABA(C) receptors.

Authors:  Maria Grazia Zizzo; Flavia Mulè; Rosa Serio
Journal:  Neuropharmacology       Date:  2007-04-14       Impact factor: 5.250

10.  Ionotropic GABA receptors with mixed pharmacological properties of GABAA and GABAC receptors.

Authors:  Kristin Hartmann; Frank Stief; Andreas Draguhn; Christiane Frahm
Journal:  Eur J Pharmacol       Date:  2004-08-23       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.